Disclosed are pharmaceutical compositions comprising a compound having the formula: or a pharmaceutically acceptable salt thereof, or a hydrate of thereof, and at least one pharmaceutically acceptable polymer. The pharmaceutically acceptable salt of the compound of Formula I, or a hydrate thereof, can be a mesylate salt, including, for example, a mono-mesylate or a bis-mesylate salt, or a hydrate thereof. Also disclosed are methods of use for the pharmaceutical composition.本發明揭示了藥學組成物，其包含具有下式的化合物：或其藥學上可接受的鹽類、或其水合物，以及至少一種藥學上可接受的聚合物。式I化合物之藥學上可接受的鹽類或其水合物可為甲烷磺酸鹽，包括：例如，單甲烷磺酸鹽或雙甲烷磺酸鹽或是彼等之水合物。本發明還揭示了該藥學組成物的使用方法。
